Announcements Trials
Browse Landscape

Phase

Phase NA 20Phase 2/3 2Phase 2 2Phase EARLY_PHASE1 1Phase 4 1

Status

Completed 14Recruiting 8Unknown 3Withdrawn 2Terminated 2Not yet recruiting 1Active not recruiting 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Conditions

Breast Neoplasms 412Carcinoma, Non-Small-Cell Lung 285Prostatic Neoplasms 208Neoplasms 202Neoplasm Metastasis 179Melanoma 164Multiple Myeloma 158Colorectal Neoplasms 157Leukemia, Myeloid, Acute 143Lung Neoplasms 132Leukemia 126Lymphoma 118Pancreatic Neoplasms 117Recurrence 111Ovarian Neoplasms 111Leukemia, Lymphocytic, Chronic, B-Cell 110Lymphoma, Non-Hodgkin 104Carcinoma, Renal Cell 104Brain Neoplasms 89Myelodysplastic Syndromes 88Precursor Cell Lymphoblastic Leukemia-Lymphoma 86Glioblastoma 84Lymphoma, Large B-Cell, Diffuse 80Lymphoma, Follicular 79Carcinoma, Hepatocellular 79Head and Neck Neoplasms 77Squamous Cell Carcinoma of Head and Neck 76Urinary Bladder Neoplasms 66Stomach Neoplasms 61Hodgkin Disease 59

Interventions

Psychotherapy 1N-Methyl-3,4-methylenedioxyamphetamine 1Ketamine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 2 × Terminated × Anxiety Disorders × Clear all
NCT00252174 2017-11-14

MDMA-assisted Therapy in People With Anxiety Related to Advanced Stage Cancer

Brigham and Women's Hospital

Phase 2 Terminated
2 enrolled 6 charts

Anxiety Disorders, Neoplasms

NCT01680172 2016-02-29

Oral Ketamine in the Treatment of Depression and Anxiety in Patients With Cancer

Mayo Clinic

Phase 2 Terminated
5 enrolled 6 charts

Anxiety Disorders, Depression, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡